Dec. 28, 2022
EG-011: WASp as a New Target for Heme Cancers
EG-011
WASp activator in vivo antitumor activity fortuitous scaffold hopping from ibrutinib bioRxiv, 25 November 2022 Institute of Oncology Research, Bellinzona, CH
WASp activator in vivo antitumor activity fortuitous scaffold hopping from ibrutinib bioRxiv, 25 November 2022 Institute of Oncology Research, Bellinzona, CH